NCT04606940View on ClinicalTrials.gov

Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN)

CompletedOBSERVATIONAL
Enrollment

18

Participants

Timeline

Start Date

October 19, 2020

Primary Completion Date

October 12, 2021

Study Completion Date

October 12, 2021

Conditions
Head and Neck CancerAdvanced CancerMetastatic CancerHNSCCSquamous Cell Carcinoma
Trial Locations (1)

M5G 2M9

Princess Margaret Cancer Centre, Toronto

All Listed Sponsors
collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University Health Network, Toronto

OTHER

NCT04606940 - Study of Circulating Tumor DNA (ctDNA) Kinetics in Immuno-oncology (IO-KIN) | Biotech Hunter | Biotech Hunter